DK1644739T3 - Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner - Google Patents

Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner

Info

Publication number
DK1644739T3
DK1644739T3 DK04767522T DK04767522T DK1644739T3 DK 1644739 T3 DK1644739 T3 DK 1644739T3 DK 04767522 T DK04767522 T DK 04767522T DK 04767522 T DK04767522 T DK 04767522T DK 1644739 T3 DK1644739 T3 DK 1644739T3
Authority
DK
Denmark
Prior art keywords
cell
detecting
event
binding
solubilization
Prior art date
Application number
DK04767522T
Other languages
English (en)
Inventor
Francois Ichas
Giorgi Ichas Francesca De
Pier-Vincenzo Piazza
Jean Dessolin
Laura Schembri
Flora Tomasello
Lydia Lartigue
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1644739T3 publication Critical patent/DK1644739T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK04767522T 2003-07-04 2004-06-30 Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner DK1644739T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308186A FR2857098B1 (fr) 2003-07-04 2003-07-04 Procede de mise en evidence d'un evenement moleculaire dans une cellule grace a des proteines marqueurs fluorescentes.
PCT/FR2004/001678 WO2005012913A2 (fr) 2003-07-04 2004-06-30 Procede de mise en evidence d'un evenement moleculaire dans une cellule grace a des proteines marqueurs fluorescentes

Publications (1)

Publication Number Publication Date
DK1644739T3 true DK1644739T3 (da) 2008-08-25

Family

ID=33522767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04767522T DK1644739T3 (da) 2003-07-04 2004-06-30 Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner

Country Status (10)

Country Link
US (2) US20070042445A1 (da)
EP (1) EP1644739B1 (da)
JP (2) JP4864702B2 (da)
AT (1) ATE393392T1 (da)
CA (1) CA2531225A1 (da)
DE (1) DE602004013320T2 (da)
DK (1) DK1644739T3 (da)
ES (1) ES2305837T3 (da)
FR (1) FR2857098B1 (da)
WO (1) WO2005012913A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2683816B1 (en) * 2011-03-11 2017-05-10 Merz Pharma GmbH & Co. KGaA Method for the determination of botulinum neurotoxin biological activity
WO2018235251A1 (ja) * 2017-06-23 2018-12-27 株式会社ニコン 解析装置、解析プログラム及び解析方法
CN109251492B (zh) * 2017-07-13 2022-10-28 新加坡国立大学 生物墨水及其制备方法和应用
CN111272518B (zh) * 2020-01-16 2022-07-01 南方医科大学南方医院 一种荧光探针及其在细胞染色中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618794B2 (fr) * 1987-02-16 1991-03-15 Agronomique Inst Nat Rech Vecteur de clonage du gene de structure de la nitrate reductase et sonde d'adn obtenue
GB9301553D0 (en) * 1993-01-27 1993-03-17 Univ Wales Protein synthesis
WO1997037020A1 (en) * 1996-04-01 1997-10-09 Genentech, Inc. Apo-2li and apo-3 apoptosis polypeptides
AU6440798A (en) * 1997-02-26 1998-09-18 Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulation of vesicular release
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6828106B2 (en) * 1999-02-26 2004-12-07 Cyclacel Limited Methods and compositions using coiled binding partners
WO2000073437A1 (en) * 1999-05-27 2000-12-07 Merck Frosst Canada & Co. Assays for caspase activity using green fluorescent proteins
US6110691A (en) * 2000-01-06 2000-08-29 Board Of Regents, The University Of Texas System Activators of caspases
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2001092527A2 (en) * 2000-06-01 2001-12-06 Incyte Genomics, Inc. Regulators of apoptosis
GB0111146D0 (en) * 2001-05-04 2001-06-27 Imp College Innovations Ltd Methods
US6979530B2 (en) * 2001-05-21 2005-12-27 Applera Corporation Peptide conjugates and fluorescence detection methods for intracellular caspase assay
US20070015145A1 (en) * 2001-08-14 2007-01-18 Clifford Woolf Nucleic acid and amino acid sequences involved in pain
AU2002330022B2 (en) * 2001-09-13 2007-07-12 California Institute Of Technology Method for producing transgenic birds and fish
US20030138419A1 (en) * 2001-11-16 2003-07-24 The University Of Tennessee Research Corporation Recombinant antibody fusion proteins and methods for detection of apoptotic cells

Also Published As

Publication number Publication date
FR2857098A1 (fr) 2005-01-07
CA2531225A1 (fr) 2005-02-10
ES2305837T3 (es) 2008-11-01
EP1644739A2 (fr) 2006-04-12
JP4864702B2 (ja) 2012-02-01
WO2005012913A3 (fr) 2005-04-21
JP2007515929A (ja) 2007-06-21
EP1644739B1 (fr) 2008-04-23
JP2011135885A (ja) 2011-07-14
US20070042445A1 (en) 2007-02-22
WO2005012913A2 (fr) 2005-02-10
FR2857098B1 (fr) 2006-05-05
DE602004013320D1 (de) 2008-06-05
ATE393392T1 (de) 2008-05-15
DE602004013320T2 (de) 2009-05-14
US20120040389A1 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
WO2008042003A3 (en) Method and composition for rapid viability testing of cells
BRPI0515079A (pt) marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados
BRPI0417903A (pt) método de melhorar a detecção de sinal de um componente de parede celular de células
BRPI0705622A (pt) dispositivo de rele e correspondente método
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
WO2002095356A3 (en) Methods and compositions for analyzing proteins
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
WO2006017751A3 (en) Methods for the detection of molecular interactions within cells
ATE426858T1 (de) System und verfahren zum erkennen von bísartigem code
DE60135839D1 (de) Nachweis von analyten
WO2006053251A3 (en) Method of measuring amyloid-beta peptides
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
DK1644739T3 (da) Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
ATE546731T1 (de) Schnelles homogenes immunoassay unter verwendung von elektrophorese
WO2002038799A3 (en) Detection of proteases and screening for protease inhibitors
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
WO2006089801A3 (de) Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide
TW200512459A (en) Global analysis for protein expression kit and protein qualitative and quantitative method thereof
ATE511092T1 (de) Direkter nachweis von molekülen in polyacrylamidgel
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
Zinellu et al. Distribution of low‐density lipoprotein‐bound low‐molecular‐weight thiols: A new analytical approach
DK1382691T3 (da) Fremgangsmåde til isolering af 20S-proteasomet samt fremgangsmåde til identifikation af inhibitorer af 20S- og 26S-proteasomet
ATE446512T1 (de) Doppeltes hybridsystem auf der basis von gen- silencing durch transkriptionelle interferenz